Table 1.

Baseline characteristics of the pravastatin and usual care subgroups, according to ACE insertion/deletion genotype.

	ACE Genotype
	II		ID		DD
Characteristic	Pravastatin	Usual care	Pravastatin	Usual care	Pravastatin	Usual care
Sample size	951 (20.1)	922 (19.5)	2376 (50.1)	2336 (49.4)	1414 (29.8)	1468 (31.1)
Age	65.95 (7.5)	66.13 (7.8)	66.64 (7.7)	66.17 (7.4)	66.32 (7.8)	66.34 (7.6)
Race
White	551 (57.9)	567 (61.5)	1358 (57.2)	1367 (58.5)	778 (55.1)	806 (54.9)
Black	304 (32.0)	274 (29.7)	897 (37.8)	824 (35.3)	572 (40.4)	587 (40.0)
Other	96 (10.1)	81 (8.8)	121 (5.0)	145 (6.2)	64 (4.5)	75 (5.1)
Gender (Male)	481 (50.6)	471 (51.1)	1218 (51.3)	1185 (50.7)	735 (52.0)	747 (50.9)
Lipid Meds in last year	14 (1.5)	19 (2.1)	38 (1.6)	33 (1.4)	27 (1.9)	20 (1.4)
SBP, mm Hg	145 (13.9)	146 (14.2)	145 (14.1)	145 (13.9)	145 (13.7)	145 (14.1)
DBP, mm Hg	84 (9.7)	84 (9.9)	84 (10.0)	84 (9.7)	84 (9.6)	84 (10.0)
Smoker	211 (22.2)	245 (26.6)	548 (23.1)	525 (22.5)	353 (25.0)	339 (23.1)
History of diabetes	359 (37.8)	286 (31.0)	843 (35.5)	834 (35.7)	477 (33.7)	501 (34.1)
History of MI or Stroke	164 (17.3)	145 (15.7)	397 (16.7)	408 (17.5)	248 (17.5)	268 (18.3)
History of CHD	131 (13.8)	146 (15.8)	333 (14.0)	344 (14.7)	178 (12.6)	227 (15.5)
BMI	30.1 (6.0)	29.7 (6.2)	29.8 (5.9)	29.9 (6.1)	29.8 (5.9)	30.2 (6.2)
Total cholesterol	224.7 (26.2)	223.1 (26.3)	223.2 (27.3)	223.5 (26.3)	223.5 (26.9)	223.9 (26.6)
HDL cholesterol	47.0 (13.6)	46.9 (13.5)	47.6 (13.4)	47.2 (13.2)	47.9 (13.3)	47.7 (13.9)
LDL cholesterol	145.5 (20.5)	144.9 (20.9)	145.2 (21.9)	145.3 (21.4)	145.8 (21.1)	145.5 (21.3)
Antihypertensive treatment group
Doxazosin	180 (18.9)	194 (21.0)	497 (20.9)	508 (21.8)	316 (22.3)	309 (21.1)
Chlorthalidone	367 (38.9)	348 (37.7)	838 (35.3)	850 (36.4)	513 (36.3)	516 (35.2)
Amlodipine	196 (20.6)	197 (21.4)	536 (22.6)	501 (21.5)	292 (20.7)	315 (21.5)
Lisinopril	208 (21.9)	183 (19.9)	505 (21.3)	477 (20.4)	293 (20.7	328 (22.3)